Send me a link:

*Text messaging rates may apply.

 Dow Down 0.02% Nasdaq Down 0.04%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
9.45 0.21(2.17%) Jul 24, 3:59PM EDT
|After Hours : 9.45 0.00 (0.00%) Jul 24, 6:17PM EDT
Prev Close:9.66
Open:9.72
Bid:9.32 x 200
Ask:9.60 x 1000
1y Target Est:7.33
Beta:0.53
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:9.41 - 9.74
52wk Range:7.38 - 10.21
Volume:1,552,817
Avg Vol (3m):2,148,130
Market Cap:1.52B
P/E (ttm):5.44
EPS (ttm):1.74
Div & Yield:0.60 (6.10%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIDown 2.17%1.52B
AMGN92.55B
SGEN4.27B
XOMA435.07M

Key Statistics

Forward P/E (1 yr):4.63
P/S (ttm):3.16
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.06
Quarterly EPS Est (Jun-14) :0.46
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.33

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback